LES (USA & Canada) Editorial Board
Regional Vice President, USA
Pamela Demain, Executive Director, Corporate Licensing, Merck & Co., Inc.
High Technology Sector
Michael Plonka, Manager, The Poirier Group
Life Sciences Sector
Gwen Melincoff, Senior Vice President, Business Development, Shire Pharmaceuticals, Inc.
Fernando Salles, External Scientific Affairs, Merck Research Laboratories
Chemicals, Energy, Environmental and Materials Sector
Ida Shum, Business Development Executive, Lawrence Livermore National Laboratory
Industry-University-Government Interface Sector
Elaine White, Associate Director, Office of Technology Transfer & Commercialization, University of North Texas Health Science Center
Consumer Products Sector
Susan Levy, Consultant
International
John Paul, Attorney, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Licensing Office and Structure Management
Matt Raymond, Director of Intellectual Property, Rush University Medical Center
Valuation & Taxation
Kevin Arst, Managing Director, 284 Partners, LLC
Bruce Berman, CEO, Brody Berman Associate., Inc.
Brian Frizzell, Associate Principal, Charles River Associates (CRA)
Women in Licensing
Adrienne Robinson, Director, Merck & Co., Inc.
Quality Assurance
John Ramsay, Attorney